OMB’s FY2026 NIH Funding Slowdown: What Researchers Need to Know

Hook

The Office of Management and Budget (OMB) has issued a delay on releasing FY2026 funds to the National Institutes of Health (NIH), effectively slowing down the pace of new grant awards and instructing NIH to restrict spending to essential activities only. For thousands of researchers and institutions dependent on reliable NIH funding, this move introduces new hurdles—potentially impacting grant cycles, timelines, and the broader scientific enterprise.

Context

While OMB actions to pause funding are not without precedent, this specific delay for FY2026 has arrived at a particularly sensitive point. Traditionally, even when Congress’s appropriations run behind, NIH operates under continuing resolutions, allowing the agency to proceed with reviewing proposals and making funding commitments with some confidence. However, this year the OMB has opted to restrict NIH’s ability to commit resources beyond essential operations until a full federal budget is authorized, compressing award timelines and heightening uncertainty for a vast research community.

Earlier, similar pauses were seen in 2025, when the OMB (under executive branch direction) temporarily halted new HHS and NIH grant programs, a situation that only began to ease after legal intervention by federal courts (source). In 2025, existing grant obligations were honored, but new awards, continuations, and supplements faced postponements. This background provides important context for what’s happening today: agencies and grant seekers are once again forced into a holding pattern, with critical timelines at risk.

Impact

For researchers actively seeking new NIH funding, this means that review cycles and award announcements may be delayed. Grant applicants in the final stages of review may find themselves waiting weeks—or even months—for funding decisions or award activation. For established grantees, work that is already obligated (i.e., under legal contract) can typically continue, but proposals (including renewals and supplements) may not advance until the OMB lifts their restriction.

Nonprofit research institutions and universities may face budget instability as anticipated grant flows are delayed. Administrators will need to manage cash flow carefully, possibly reprioritizing research projects or instituting temporary hiring or spending freezes. Junior scientists, trainees, and early-career PIs are likely to feel the shock most acutely, as bridge funding and start-up packages often depend on anticipated awards.

For small businesses seeking to access NIH’s Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) programs, the disruption is particularly acute. SBIR/STTR funds are often the lifeblood for R&D-intensive startups, and any delay in federal funds can put both project momentum and company stability at risk.

Action Steps

Grant seekers should take several concrete steps right now:

1. Stay Informed: Monitor the NIH Grants & Funding Announcements page and your Institute’s notices for real-time updates. Join mailing lists and attend webinars aimed at addressing the impact of current funding delays.
2. Communicate with Program Officers: Reach out to NIH program staff to confirm the status of any pending or upcoming awards.
3. Update Internal Stakeholders: If you are a grant administrator or PI, update your team and institute leadership on anticipated delays and potential impacts on payroll or project timelines.
4. Prepare Financial Contingencies: Consider strategies such as bridging funds from other sources, or revising project scopes to focus on essential activities while waiting for federal approvals.
5. Document All Communications: Keep clear records of any instructions or notices received from NIH, OMB, or your institution’s sponsored programs office.

Outlook

Congress ultimately controls the federal appropriations process, and as seen in early 2025, delays imposed by the executive branch can be time-limited or overridden via legislative or judicial action. Researchers and institutions should expect communication from NIH about relaxed deadlines, procedural waivers, or transition flexibilities once the budget impasse resolves. In the near term, vigilance and adaptability will be crucial.

Granted AI will continue to track policy changes and help grant seekers navigate delays, find alternate opportunities, and prepare competitive proposals in a shifting environment.